<SEC-DOCUMENT>0001493152-26-020586.txt : 20260430
<SEC-HEADER>0001493152-26-020586.hdr.sgml : 20260430
<ACCEPTANCE-DATETIME>20260430163018
ACCESSION NUMBER:		0001493152-26-020586
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260430
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cocrystal Pharma, Inc.
		CENTRAL INDEX KEY:			0001412486
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				352528215
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38418
		FILM NUMBER:		26926107

	BUSINESS ADDRESS:	
		STREET 1:		19805 N. CREEK PARKWAY
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011
		BUSINESS PHONE:		(786) 459-1831

	MAIL ADDRESS:	
		STREET 1:		19805 N. CREEK PARKWAY
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOZONE PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20110304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	International Surf Resorts, Inc.
		DATE OF NAME CHANGE:	20070917
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:COCP="http://cocrystalpharma.com/20260430">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_COCP_cocrystalpharma.com_20260430 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20260430_20260430 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001412486 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000004" name="dei:EntityCentralIndexKey">0001412486</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cocp-20260430.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001412486</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-04-30</xbrli:startDate>
        <xbrli:endDate>2026-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_905_edei--DocumentType_c20260430__20260430_z6HUHEL1vlVb"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90B_edei--DocumentPeriodEndDate_c20260430__20260430_zD4kg61cQFZk"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April 30, 2026</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityRegistrantName_c20260430__20260430_zAUe0yD91sGe"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000011" name="dei:EntityRegistrantName">Cocrystal
Pharma, Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20260430__20260430_zq7iodYn1io8"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFileNumber_c20260430__20260430_z87U5eqzFia7"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000013" name="dei:EntityFileNumber">001-38418</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20260430__20260430_z6VASeRbgAA6"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000014" name="dei:EntityTaxIdentificationNumber">35-2528215</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other Jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    Incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressAddressLine1_c20260430__20260430_zFaudbp1UbBj"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000015" name="dei:EntityAddressAddressLine1">19805
    N. Creek Parkway</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityAddressCityOrTown_c20260430__20260430_zZnbEPxOVdwj"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000016" name="dei:EntityAddressCityOrTown">Bothell</ix:nonNumeric></span>,
    <span id="xdx_901_edei--EntityAddressStateOrProvince_c20260430__20260430_zTAhWqLNlJwg"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000017" name="dei:EntityAddressStateOrProvince">WA</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityAddressPostalZipCode_c20260430__20260430_zOAUsdy9ZTXe"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000018" name="dei:EntityAddressPostalZipCode">98011</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span style="text-decoration: underline"><span id="xdx_902_edei--CityAreaCode_c20260430__20260430_zw5iOOvQ4IL2"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000019" name="dei:CityAreaCode">(877)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20260430__20260430_zbNF3UY6niEb"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000020" name="dei:LocalPhoneNumber">262-7123</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report.): n/a</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20260430__20260430_z2bwIKvXZ7H3"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20260430__20260430_zzmpxQ8pBdDi"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20260430__20260430_zhxM5RVXywIi"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20260430__20260430_zuuQ4AMHWWS2"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20260430__20260430_zh1ersrq98W2"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt:booleanfalse" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of Each Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_902_edei--Security12bTitle_c20260430__20260430_z2FM2QQsyPol"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000026" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90F_edei--TradingSymbol_c20260430__20260430_zrB9wdubjv2l"><ix:nonNumeric contextRef="AsOf2026-04-30" id="Fact000027" name="dei:TradingSymbol">COCP</ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90B_edei--SecurityExchangeName_c20260430__20260430_zwhQ9rryKA3b"><ix:nonNumeric contextRef="AsOf2026-04-30" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market, LLC</ix:nonNumeric></span></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span>(The
    Nasdaq Capital Market)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2026, Cocrystal Pharma, Inc. (the &#8220;Company&#8221;) issued a press release, announcing that the mechanism of action and
clinical advancement of its first oral protease inhibitor CDI-988 were featured today in an oral presentation at the 39th International
Conference on Antiviral Research (ICAR 2026) in Prague, Czech Republic. A copy of the press release is furnished as Exhibit 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 7.01 (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities
Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under such section, and shall not be deemed
to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated April 30, 2026</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cocrystal
    Pharma, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 30, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    James Martin</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
Martin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief
Executive Officer and Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFj2FrwjAQhn9B/8ORz6JpLML6zRUVWR2jk7GvsT1HsMmVS3T6k/YvF9PJwkG4e9/n3kSIidjQ2vTI8Pnc1LBHO/Q6IDR4REbXYnRU25cS4t3gl/GBtQupfYAVRQYjs5gWhzhPzovx2JUgi9lcztQC5FNZzGG5E9ldr8gdTYcuGN2Ddh28MQ1sMGi+jRv2+kqO7C0lfSB7Q66EfCpH+QeUzBW80kV/E5881HUlskk6mdgwnYfoWl0DujsJqx5tjPMj/V/pNe3ZB7Jl/Icl9x6oPe3QHpCjlEulcrn8Sx0dkCyPBb9DEl0D -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cocrystal
Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment
of Norovirus Infection</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ongoing
                                            Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to
                                            demonstrate proof-of-concept as a preventive and a treatment</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fully
                                            enrolled first cohort is assessing the infectivity of the human challenge inoculum</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>There
                                            are no approved treatments or vaccines for norovirus, the leading cause of acute gastroenteritis
                                            across all age groups and geographies with a $60 billion annual economic burden</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FDA
                                            Fast Track designation granted for CDI-988 underscores the lack of approved therapies and
                                            seriousness of norovirus infection </I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOTHELL,
Wash. (April 30, 2026)</B> &ndash; Cocrystal Pharma, Inc. (Nasdaq: COCP) (&ldquo;Cocrystal&rdquo; or the &ldquo;Company&rdquo;) announces
that the mechanism of action and clinical advancement of its first oral protease inhibitor CDI-988 were featured today in an oral presentation
at the 39<SUP>th</SUP> International Conference on Antiviral Research (ICAR 2026) in Prague, Czech Republic. The presentation, titled
&ldquo;First Oral Direct-Acting Antiviral CDI-988 for Norovirus Infection Prevention and Treatment: Novel Mechanism of Action and Phase
1 Study Results,&rdquo; was delivered by Sam Lee, Ph.D., President and co-CEO of Cocrystal. Presentation slides are available on the
Company&rsquo;s website <U>here</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;It
was an honor to share our progress with CDI-988 with the global antiviral research community attending ICAR 2026,&rdquo; said Dr. Lee.
&ldquo;Following favorable Phase 1 data, we have advanced CDI-988 into a Phase 1b study under a human challenge model that provides an
efficient framework to rapidly demonstrate proof of concept as a preventive and as a treatment for norovirus infection. We have now completed
enrollment of the stage 1 study cohort, which will establish the infectivity rate of the GII.2 (Snow Mountain Virus) challenge inoculum.
This is a critical step in validating infectivity in the study cohorts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Multiple
norovirus vaccine clinical studies have been initiated over the past decade, yet none have led to an approval in part due to the virus&rsquo;s
extensive genetic variation and drift, spanning 10 genogroups and 49 genotypes,&rdquo; Dr. Lee added. &ldquo;CDI-988 is designed to target
the highly conserved region of the 3CL protease across all known norovirus strains, including GII.4 and the re-emerging GII.17 variants,
as well as all coronaviruses. We believe this compound could offer a much-needed option for prevention and treatment in a convenient
oral formulation that can be readily stockpiled in advance of norovirus outbreaks.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDI-988
is a first, oral direct-acting antiviral and was developed using Cocrystal&rsquo;s proprietary structure-based drug discovery platform
technology. As presented by Dr. Lee, in preclinical studies CDI-988 showed favorable gastrointestinal-targeted pharmacokinetics at the
site of norovirus infection and also demonstrated potent antiviral activity in GII.4-infected human enteronoid model systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In
a completed randomized, double-blind, placebo-controlled single- and multiple-ascending dose Phase 1 study in healthy adults, CDI-988
was generally safe and well tolerated across doses up to 1,200 mg, with headache as the most common treatment-emergent adverse event
and no serious adverse events reported. These results, together with a no-observed adverse effect of 1,000 mg/kg in GLP toxicology studies,
support CDI-988&#8217;s further clinical development in norovirus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ongoing Phase 1b randomized, double-blind, placebo-controlled challenge study (<U>NCT07198139</U>) is being conducted at Emory University
School of Medicine in collaboration with the University of North Carolina. The study is designed to enroll up to 40 healthy adults, ages
18 to 49, in staged cohorts. The stage 1 infectivity cohort, now fully enrolled, will be followed by prevention and treatment cohorts
in which CDI-988 is administered at 1,200 mg twice daily for five days. The primary efficacy endpoint is reduction in the incidence of
clinical symptoms, with secondary endpoints including reduction in viral shedding, disease severity, safety and pharmacokinetics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDI-988
has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment and prophylaxis of norovirus
infection, underscoring the serious nature of norovirus disease and the lack of approved therapies. Fast Track status is intended to
facilitate development and expedite the review of drugs that address unmet medical needs, providing opportunities for more frequent FDA
interactions, rolling review of a potential New Drug Application and potential eligibility for Priority Review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Norovirus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norovirus
is the leading cause of acute gastroenteritis among all age groups and all geographic regions. It is highly contagious and causes symptoms
including nausea, vomiting, stomach pain, diarrhea, fatigue, fever and dehydration. It is notorious for outbreaks in semi-closed environments
such as hospitals, nursing homes, cruise ships, schools and military facilities. Norovirus is responsible for an <U>estimated 685 million
cases and an estimated 200,000 deaths globally each year, with an approximate $60 billion in worldwide economic impact. In the United
States alone, the virus is associated with 21 million infections annually, resulting in around 109,000 hospitalizations, 465,000 emergency
department visits and 900 deaths</U>. The estimated annual economic burden in the <U>U.S. exceeds $10.6 billion</U>. In developing nations,
norovirus contributes <U>up to 1.1 million hospitalizations and 218,000 pediatric deaths each year</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ICAR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hosted
by the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR) brings together
leading scientists, researchers and industry professionals from around the world to discuss the latest advancements and breakthroughs
in antiviral research. ICAR provides a variety of networking opportunities allowing members to connect with colleagues and establish
new scientific relationships and collaborations with leaders in the antiviral field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cocrystal Pharma, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cocrystal
Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication
process of noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2), and rhinoviruses. Cocrystal employs unique structure-based
technologies and Nobel Prize-winning expertise to create viable antiviral drugs. For further information about Cocrystal, please visit
<U>www.cocrystalpharma.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including
statements regarding any implications that CDI-988 is able to prevent and/or treat norovirus infections. The words &ldquo;believe,&rdquo;
&ldquo;may,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;should,&rdquo;
&ldquo;plan,&rdquo; &ldquo;could,&rdquo; &ldquo;target,&rdquo; &ldquo;potential,&rdquo; &ldquo;is likely,&rdquo; &ldquo;will,&rdquo;
&ldquo;expect&rdquo; and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based
these forward-looking statements largely on our current expectations and projections about future events. Some or all of the events anticipated
by these forward-looking statements may not occur. Important factors that could cause actual results to differ from those in the forward-looking
statements include, but are not limited to, <FONT STYLE="background-color: white">the risks and uncertainties arising from delays arising
from raw materials and labor shortages, supply chain disruptions and other business interruptions including any adverse impacts on our
ability to obtain raw materials for and otherwise proceed with studies as well as similar problems with our vendors and our current and
any future clinical research organization (CROs) and contract manufacturing organizations, the progress and results of the studies including
any adverse findings or delays, the ability of us and our CROs to recruit volunteers for, and to otherwise proceed with, clinical studies,
our and our collaboration partners&rsquo; technology and software performing as expected, financial difficulties experienced by certain
partners, the results of any current and future preclinical and clinical studies, general risks arising from clinical studies, receipt
of regulatory approvals, regulatory changes and any adverse developments which may arise therefrom, and general economic adverse effects
from the ongoing conflict with Iran. </FONT>Further information on our risk factors is contained in our filings with the SEC, including
the &ldquo;Risk Factors&rdquo; in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. Any forward-looking
statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to
differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update
any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alliance
Advisors IR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jody
Cain</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310-691-7100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jcain@allianceadvisors.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N /H# 2(  A$! Q$!_\0
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M1SPRQRI@,&/"C[FD@B#%0SC<%.P.0#L+8&0,DY;N2P/S*0<D_!__  4_4?\
M#O\ _:J7#;#\*M05E) VC^T]+' R,<9 P!CC)XX_,JG%E3C;CO@[,L=DN195
MB89MP[A,Q>2X&& HYSB/[;P'M,=C</2G[)5ZU.4(3ITZ482Y97K5O:WH_LU+
MP_I>&GA7XCY/EO$O$^<Y=4R'BS&Y9#B#-JV:8CAW#?ZMYDJ64Y7BYQ^M0P5*
MI3GB(SJUE)UITY*GAO8I5?YE_P!B7]B?]KS]N/X=^+/B7\/_ -JK7_!>E>#_
M !Y=^ ;[3/&7Q&^,-Q?WU_;^&O#OB?[?;/HNKS0)8&V\26=LJR8<30W,D<-O
M&D2M[O\ %[_@G?\ \%-OV2_!&M_'#P1^U)X@\=VW@#39_$GB.S^'_P 6/BE;
M^)['1-.0W&J:S#X?\6R#1?$-CI%@;O4]4L$N)+J:PL[MK?3;R1A$-#_@DI_P
M45_9C_8\^!/Q)\ _&W7O%ND^)?$OQAO/&FEV_A[P/K_BBUD\/R^ O /AV*XN
M+W2XW@@N9-4T#4HFLY&62.-8)V!CG4#Z[_:N_P""XG[-%[\$OB#X3^ ^G^.?
M'/C_ ,;>%M=\'Z5=>)/"C>#O!WAMO$.FW.CWFM:W<Z]=1:OJ T^TO9KRPTK2
M]*NX=1OH[2TO+[2[6:>[3^BN(\S\8*7B'CLHR?@?+<TX/_MW#X;"1Q_!.4/*
ML9E,H9=4Q$J^<5:-.M&@Z4LRG];56I4HQH3G]7JJRC_'W!V2?1[J>$F3Y_GW
MB1FF2^(/^K5?&XV&6>(/$$,[P>?TWG-?!T<-D5.I*E5Q$ZV&RFG]35H2CB%*
M6)PC_P!KI?4__!)']NSQ?^V7\)/&&D_%AK&X^,'P:U70--\3>)--L].TFR\;
M>'O%$&I77AGQ0^BZ=;6>G:;JJSZ-K&BZY;Z7:6^ER7.GVVHV,%DFI'3;3\J?
M^"A_A#X_?\$YOVOO O[4?P?\<?$+4O@GXU\9OXKTKPQKGCOQ7J7@O2O&#M=7
M?Q ^#&LZ5JFJ:G90^%O%N@G5-4\+%K6$Z9I-YJ5KX?M[>Y\%V]\WV5_P0=_9
M>\?_  B^%OQ1^-/CS1-1\,P_&N;P;IGP_P!'UJRN=-UB?P3X'3Q%+_PE-UI]
M[&E[::?XBU;Q 4\/->QP3:AH^EQZW;1R:7J^F74_Z]_M.?L\> OVH_@GXX^"
M7Q ME&E>+]/8:;K$=O%-J/A3Q59C[1X:\9:,7*%=5\.ZIY%_%'YB17UNMWIE
MYYECJ%Y%+^1X[B'A;@/QBXCH97@L%C^!LQQ$<GS[*(TZ>*P:PN/P6%_MB&"Y
M^9*64X_$XN6%]E4=6E"EB<MC4<72]E^^95P=QKXK?1UX-Q.>9AFN5^)^58/_
M %CX6S[$U<1@<S>8Y9F&*J9#/-%6GA:T7G.583"TL6\90<:M6OEN9XB+G#$5
M,1N? ?XV>"/VC/A!X!^-'P[U%KGPKX_T"#5K:*<1_;M$OL-!KGAW5T( @UGP
MUK-O?:)J]N"\:7EC,T,LL$EO/+_,C^UM^T+\8?\ @I?^W?X/_9A_9:\?>)_#
M/PL\#:MJ?AS3?%_A'Q#K>AZ=J:V"V5S\5?C/XAET*^T>?4M T&*S;1? MK>7
MSVFK&UL9M#FM[_QZ\2_$5M^T7^U/_P $_?"W[6'[#5\6T*X\8ZLNAW6HI=7T
M-SX0N)VM[37_ !A\.66$R7%A\7O 'V*"SOG\F2"UGTO7=/6VUVWO8IOZ./\
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B#24IVM;F=DI.22TT3:3:O>UTM&FTFVE>W6_J:M%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cocp-20260430.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKLWbP9z5Z8eekhvWB9bRn6/yYu9t14IimyPDkWUWYF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:COCP="http://cocrystalpharma.com/20260430" elementFormDefault="qualified" targetNamespace="http://cocrystalpharma.com/20260430">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cocrystalpharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cocp-20260430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cocp-20260430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cocp-20260430_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cocp-20260430_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cocp-20260430.xsd#Cover" roleURI="http://cocrystalpharma.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 30, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cocrystal
Pharma, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001412486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">35-2528215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">19805
    N. Creek Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bothell<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">262-7123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COCP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cocrystalpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cocp-20260430.xsd</File>
    <File>cocp-20260430_lab.xml</File>
    <File>cocp-20260430_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "COCP",
   "nsuri": "http://cocrystalpharma.com/20260430",
   "dts": {
    "schema": {
     "local": [
      "cocp-20260430.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cocp-20260430_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cocp-20260430_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://cocrystalpharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cocrystalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-26-020586-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-020586-xbrl.zip
M4$L#!!0    ( ,B#GEQ*(]</+@,  /<+   1    8V]C<"TR,#(V,#0S,"YX
M<V2U5MMRVC 0?>],_T'UNS&$0 .!=%J8=)B2AH$F)'WI"'L!#;+D2C*7?GTE
M7[@97*"MG^35.6=WM;NR&Q^6/D5S$))PUK1*A:*%@+G<(VS2M)X&]L=!J].Q
MT(>[MV^0?AKO;!O=$Z!>';6Y:W?8F-^BK]B'.OH,# 167-RB9TQ#8^'WA()
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M;0]G@THOR)A6K< <9.'A8GCK@T4&R/6,#/&)2;&PNN5WG+TD-(*7S)#<"S"
M:2LUFC8\=.P&^_BI%\0JSNM84R[*>[\D2N9GE&F;M \QI28\2-K&>@>74NT3
MB3N6Y3C]=_+<>2)N%WO!PVK8"DE+&1XJ-GM]P)0Q2 3Y.+&N<)4W-*RODFGE
M[EX!MM@ZO +<* P" ILC\Q7@\NI)*7+=S9)13C P(K2+G76RQ53=QXVR,+K8
M-&3T</&]%AH?7V29W26]>V04?D# E+CJ:<B<ZFV]/(@>!TSIO5[(4*'S=#5>
M9IC([,-WH\S9S*[;J2=R51!$[^INC&E:E3ONS=]XDHL]S]AFLZ7571[;<X.
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M:.:.J24!X6'SU9%!AB.E]<+"8H/3]/,V2RC)X(E(4[EEP6JQS4)+$A +-E\
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MS0K02CXC5E6!?I>5H*(6V^^7-S==BT]BL]HD_EKAC(@M_P502P,$%     @
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M&]/0D_^F"% <&A_4-PJ!,92$Z;)]HNO.'+!OJ\V_L;_L&UG-D?\!4$L#!!0
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MCI.N.!'8HAL>$,(T0&84#(H4HZ@B OO],8R%++F:8@IP9/B2A<BA4Z1;,#M
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M _Q640X!+^Z+#QPG[1Y-=.EMO]_W74,'QZ>_A+7=*O"^H!V-30'J45][S3G
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MR5/[<?_Q</WQ"M,7KSSU%Q1N$RU_VQ;91'-[(7^?[([1#1E$AU&J9E.T./Y
M1%'UH!0W)JEP+I0K@2P=?2)AWRG/WDJ[?:_;H5%KD2UUE5"&/,/(OL%6M#@E
M.R S*>>DV^!3%%U8%ZPW>&KOP,YD%FGN[:7^"LK8*_= H15_3 ,C]CJ-:.BG
MZWF660N1I-4ZS'".[8[<I8\$P]Y"^V4PH;;!K#Z,T93.W5^E01"DKG-JQ0E?
M$_ 3]57Z7&Y:UU2:PVP5O:WO4B$?1%-SX;M0-'O/?P+N5E?7$Y8;*ZVW8A)&
M:$?"DQ/$8Y]S.RUD-A >^9S<05.]*Z;MUQY/VP T7,\\/3#1"6M@W49T^>9H
M"1^T/N.\H,%.W& A'&&84W@^,1S1<=&((U<JN>#^4EK'"<&/X7;_?^O&!BI+
M"!>2CB%Z2BN*9T/^#/7Y  .L1*>6@X508T7* \L@H5(A+N>2G,G@SF1M>S%_
M@A0:AC17\^C=0=@"69V/+BNQ@"WC=CSH=GQ H'-U!24?&X#X^'L._'0'K$/Q
M4.3&-J6ZRGK0%--)-E$NY9C+S1NEO.8_8P 7%Q <O<)?C&)_54[[\D[MONA'
M'VFY'E[^)LSMP"5YYVTMZ05[6M)=JG,&']+CFI;[X(QVS=]?_%9I]]%GMY/(
M[PT07W?MI]D-T+ I*"D+6X[*O37<QUH2MU&2:"JZ=#NC^$9;\B"G%VNVA[^;
M&%9[A!"P9@M_A@#R8G?8?SG<WEZSI?\:0=S_([WV2*\[+B7\+?QYP3_>F+_\
MFG_H=GX0/WS#\G\X._^L]<')&75V?D_6_Z?)^F?_;K+^&TN=W^T-MNB/&[N_
M=DQ_%/E?4$L#!!0    ( ,B#GEP&623\\!(  +J8   +    9F]R;3@M:RYH
M=&WM76MWVKK2_LZOT,M9^^QD[7"QN01(PED$2$*;"P'2M/V2)=L"E!C;D6PN
M^?6O)-M@@VDN#0ETT]4V 4FC&<WHD30SE@__-Q[H8(@(Q:9Q]+>43/\-D*&:
M&C9Z1W]7VM5&X^__E6.'?9M58U4->A3OV[952J5&HU%RE$F:I)>2BL5B:LSK
MQ-U*I7%D/3F=EE+?+\[;:A\-8 (;U(:&BJ:-=&P\+*?/2Z=5%:+C4%7^C=])
M)K5 FI5JLP;!ROF46QBJ:D=6S;E5;;\JIF96EO9_Q8=;8]I@O*RNQ'EF$J+O
MQZWS674[NOZL:LHFT*!=DPR@S53(*>42:3DAYP-$$A2I(4+L<[)G#I^E4TAD
M))_.@G+"DO)B!=+IB&MH;KC]/ED!:R'G_(H.3?0@M*:5NY J@JQ7,%^9F#JB
MD;5%2:BZ:CJ&32;1C'B%H0:4V(NDV9>A2M6K:G-:2S55,F'&IEM]R 8OJ9H#
M7CF?SF;2<3YS$-3*,<#_'-K8UE'Y,.7^C!T.D T!IY- CPX>'L6KIF$CPTYT
M)A8;2-7]=!2WT=A.B>F58JU2+LG#_TLDP E&NE8";60?@$LX0"4PUL8'H%$3
MO]REY?K=3?LON79:J339#RX%2"1>V#A3N^.BWD6(>.>+^')JV>RTT1M:YXIW
MB%D.DX']K0R0H;%_]HD.>W==J%/T"DJ9 *6ZP70QJ3)2!.H-0T/CKVAREV8X
ME97D;"'_<K+Y8S;2M3OISIOR+GWVU2M(R'=M-L*(WLEW N!<&E1\]PHR-<Y)
MTR.566!H&6W%U": VA,='<6[S/1*0$I;-NC@ :MQB4:@90Z@L>=^L<?Z)[C+
M+5S#0[^9AJFEPTD)&*:!>!D>E[BU(L*F@/B -0T9?#[P3ZS6I3-@=%37UL=V
M"W6/XA5ZU>46DDAG$VP2 :P=Q4^@:J?YGTP<&$QHUA?"I9 AQ,O"$@Y3(<J_
MTU<VV%>DJ<3+,UN)ZC@5E)FS05 7$;;"(BK*.6J6J%@.&3M K'&E/N&<L5EG
M)?R)DAQ3+>X5VPP<CN(4#RP=<4#PN@E1=KNBID.\GE@EH?:2)[P0=$YX#Z;\
MFD@(['\Y_1IKO*"+$0&"<12YLE0;7\-C,]]XVEDJJC>O+XL-I*DML,"PB-@U
M:*/RC'N?SJQLOA4SE25M_)(YEH*]^]]YPQ<:4L? [GBRR34_B ,$J4-0V9N$
M)5;%)^47A>AS6M'$W?F\C+XGO*CSQ@YFH#'?"9OA3'$+ \I;"F.'MDEFI:^6
M?9Z]")J!'FO(, ?8>*;/9\=COM,(LGYQ4/SY8?2FWFRFN5/>P[S#%&M;CL5B
MA]9KD?4 #"#I8:,$>-7IOSC;/ECE=R1X +@])Z".>ZQ(9=,0D8_JA%K0"/:0
MZ,(!UMGR\4P?HB[%3\AEB5%2RO_]CY1/'QRF%,8[I^N+$%@Q6XZ.$DW8$YN%
MX++E\IRP34OP[0N14$S;-@?>=R.LV7W>8?JO>*BU8A*F;+?UL0[5!Y!E,E-3
MQ]H!\ I]2FZY-"L/BL(E\<7@=N/]'Y @%1)A:P4OMH(-$*'@B7!SV>C4:[%V
MI]*IMS=:DG:]>M-J=!KU=JQR60/U[]6SRN5I'52O+BX:[7;CZG(CQ9,]\6XA
M[6.C9YO&7JR6K":!G,YEBQLI4CH(/1O&NV]M)U>MBYA+D>]F^%&HF,Z)LUXB
M43-5AY\3^,'Z3IV>0V<GTJ?\V<U9_5P:ZM\41NZ-!X9B\, 0[#->+B2^SA\0
MID.]M9A/62P8.K7JEYU8J]Z\:G6V:O@D-30=0AUHV#';9-54[GX$4@:8!$BY
M'6T7F%W0Z2->Y!!L8T:^/E;[T&";H(IJ\V*IF,ENU?=)ZN,GYQA30@M9)K'!
M#O_,E8(@.R<A:@,T9-T"(HJ1MEL"\R!]/ ?237'NKKN'\FBTKF4?>GE)O3[Y
M^? JM'8=W$=Q/+9+&J,^8'7[&IQ,&+?("*.YE(Y"\Q!S\7+%(E@'F?0>X-UL
M$7X]>/?W!"%BHC<-J281(8X2< QV-.,!$+_7F4E6/9-TG7XMU,.4!TAL[F^-
MMLC*#4I/:D6)GJ(W[Q\D:='A&.X[7J[ZSOA84WCC]T##4)-+#6_#[6^G/F9C
M$^.#PC&%3 <#0 JHA53N2]0 9KJS*6"K H,8LKL:65<]KVRHZ(B-H:ZS;U4>
M@(TS^^"?+:AI_N=7RQ+P6TS=$:JIZ]"BC!W_-^'R.[3)&P( ;FA+FW.'^!X/
M)<KC\2K.,_)?*U_&YJ:_')K^;(*9Q/)@HVTSW*^ZH<.JJ2U!@\=]MDC\,"1L
M%MZZ/O&@+?=FV\@BYI#/@(4%2EZ$BU_R&B_7D Y';*E[#B]L;4&OK];;ZM4V
M-XLBF/X3C/$X9(PG6$=,:PHBT997V+_)H<>G$PSWW[X.918-:]8OC^M(B4PA
M*Q6V9K0Y9I0+F5$'CAM>+$X56/$KF\I_J[112^E5*OFWVU1$,'4)$_%R)I>0
M<W)!EG(OL##V'WFWU>OE+3=G#R66 2$H.U.;=A\1\(4=I:F&Q6$[N L1H[$I
M@IE=P6]HR0ON_7X3?SX;=/Y$4ZR:@P&F=).MCB^$@F,7K+8&M\[*VFFTVD+,
M^L#2S0DB&VMVX872-4 SN6!]T\4P)8Z3Y54=]>\=RKB9;,_$D?2'B-A,4[H_
M6N[&\0/.RMGB7QLT.^>WJ-G0%K6B:011ZOTXQP:2HK>G)]#1%$NZ48[OW[X]
MS2UN3R,8B)>E8B&=<Z=?$E0)0@^@"<G#"$Z>VZIN&N+,:T>*TDZ5_7I%.N;(
MB-;-3T.I-\=7W[31;^@FOU0WL^[CY6.^M=7U)6K8<P?_)3*)_?(5:1)SB UU
MB8>G4^G?/IY?ZE]&O;<+MK]4L#D>XN7;RO/VM3UP_PH8UV*^-$WNN_^)K>6^
MPZO*#=4FQ9^=[[\122@LM:P0!_$R@S-)6NTI^^7KX;KLE7>\L7(/S5U@$38)
ML05U@,9(=6P\Y.$(MAE#=/=]G%V?/>'6A=,=9IB"-VZ=NY$&^&?L;#=E%S"+
M/_[W/P59VC^@,1OIR.J;!@*&. +O 38[=(=OQP$D"#*4TI ?YG]#\-6/OO#%
MO<+H+8?*40Y?70VOLXUS^>U0&4K:"O;)K+&PO[^[!!P7]A(%C^USDR%=DX_/
MKWRJRN5)YN9'WL#UM^>;R:$,A?E^XV4Y+R?V)3GS'+QOHEUN\IS:.3$)TX07
MUB8BZH<(@.ZBPZ93%[@)3@R>^>X/Z)#Z&33)W1(P4O C!-]H)%P!\]4^4A]B
M[) !H&41DVT*>*J38HZ!@G1SQ-7&"[ER02'Q%72QSB$14X:/-F)XIP';9!H=
M.+H-#60Z5)\ RO"0=B>BI=? 5)@( B;YWH,7!/(>!&[&H#'QR[JFSCKG[7B<
M&'/?*BUMZ C_P2X@V[1^9[_KL9M.RCELK%P/\TM;Q5O:;@FVF25S+[YC>*Y(
M&KV^R<JH\77X_>?^6>;-&7J*:>H(&N*QSKF5+Y0I%<D6MZ;B?C9[L-(@]8H5
MX4DF^%-#X@'+2YOEF,(?"P)9.>>B@X"%0+HLSY+=D?9!]:0%Y$PZR2I&[ZS7
MP,X_%F#66?6+K/Z+]+0L'[-MZEAE5FWT+MC:RQ9@/1I]G@;6^+I@'6LUO KT
M"25>+?+T1T#/3"S!XL"3;1%WI"Q,2'( >D+I^5/@R::3;LTM]JR][K?8$\">
MFH<]38+X#H-?L2 >Z^([>G+5[2X[X??'%[G6M^^346,E&!3*T5O.VQ^!14R\
MA!J0[T7[(2FK)>0=9?=ER.36W6+3VMO"%IL"V'02C4T-2AU$GD4HQ[G.5B[.
M;F_;KW.?OA"ALK] J 4._\4XE4&)[([Z,ISRZFXC(VO ?,/0N%913)D E?L&
M.1\/8-1'(L=VSG&'*6#],K/@K/9 CY@CN\^-P^+./$B!AKK8<!]F<L_SZ9SO
MXYL[S+N/O&:FEL%'<?] '.W3N=V823S#DI6$'$$BZO'9>5K<UGCSW>2&*F>C
M+:ON64ELSDJ6A9S< +_?ZE0TJKIMENQ-)40H>2P6;E>"_!')5)',O1CT-TM]
M&VU[C6YL.4[Q4*\+>B ,>G@A4-%GD(9TI-H,T@Q3+'<.1:(6$\ +A_!+1[&(
M=+B7K7$#$WWI$V[^(\RZYH9O,/99"4%#3%D[!I304+DW JKB&D_.*;_Q58-$
MHVX@A-,/KK6SJP5VX*Z/BD$H3(*I,6ZDXC;:ZF;+4\RU(426Z4^<Z3S],;5M
M8UUK%^OZL'3G3&'U67U*N<.OZ_53P>I0[8.J#BD-/56_3;Q<)E3Z0U1$H.9[
MJMN3@6+J.SPS;ZN@=9E#_/(*?PHA/H60O_(R2!_U,?MFAOOSBEM7!\^*<HB7
M)L1YB^2$G<P$)BV)O)]<R-?7=-(T];=GEH52[N?[Y;>0# ;>4TAMVU0?7IAA
MML:)IYN3(AMM([XGT$-"%P2C#80<%T>:H]P/Y=\PD-"C"Z%.F75<59M;BY@1
MW[1'LI9>0>$#@7]L6GX=TJA_721D\K62>5UZZ_P%*'R9B+K[1"Y$ 520KWBY
MT_<>U(54@X\N4($+=EI%]AXX/Z^^/"WV(Y[;6GB"<TT7.W]:O/O,W1(.S^?R
MSIP!5Z&%;:A[)KRJ$, SUV!O4%;WITKR^;>0!PX%D;>09ZU/OX5\C32TF3)$
MS)>0L7$E';#6CPX/2;)60F,"JQ9M9^DE]8LR/"]\7@SQS*$5=&#-.[C";"QZ
MIN8\6(N:G"V5$0M@F'\==46+*5*'2 =K$MSKVR&0%RCK0ZSW;H>%L20(/B04
MQ#8RC#]+C']PK/+1AA+<(@9V#;/NK5"'P=FX@M<!K"VD?[23]E I-VPTB.TG
MTQ)HH9ZCBR@^.*F!&J:J;O(7BB0_ZG[-;= @S/R5$0O?O[L'IM>C@N#UJ&"'
M!POX XQR^L"+/8I/TL$NP#P510,06/SI*T"0CB!%>P :AND8'*2 W8>VB#<,
M$#]@8#K@?BSH!B2@H<54'?,,#QU ;0B]Y ]>A=]*VL6$L@^$Y\X2T^;$ 3;Z
M6,&V24"UUD@4"P4P0@2!+H*V0\1S0AJ<\$P -E)>2T093=?Z/&8R1;O/Q&-P
M;(COH1ZKFH;W%BCN5ZL8-AYBWKS%6D.B]L%.HUIIB;':Y>2;!/8<)FOUB0G&
MKW!V%!VS\:HP[+6FCQB%!H8G,G0=P@:AST>-IQ,(64"QF)2VV0*?P#P_)F!C
M^NY&KE>[S[3$D0L(Y-J9/: ;U-8NH'VHZR(\JR"@(6:WFC]-NEA'FC=)1%C6
M<HAE4L89LXII,*ZPF%\2B\XO"<S 8(7I-/3OIAMA9F/44>Y9%SSNQ]OI&"I8
M=[-7W"PIZC![I2X7?*IJ4:+P&^45/MG\"^*8=,H$3-^4QI_+,T5\V7_RSI7%
M0XCE3]/X"3CF8KK6=@9\XC)=Y,9^,DT.$)>H<"BFPD(\TZ<?O5Y[7V*#7^'%
MG^'+86.KNIGJ=K3=F*^;?X%J-C+(_P'!_'1R_YU'WS.J=XT!IY/22DUDA2'?
M]^2ZAJA*L!6Z/_83[^)]-[GXMNB=0C[K&8AZ/^"&P'U1+1H7BPDIV;<'(@&>
MG11:WDE!$SNN^5>DP/>*[:^'Q4CI[+JI9CT-IFH.$1&,"(^5.+CR(_00@1JT
M(> 7ZX(=-%"0QG,W>>ZG.,GPJORB(,#?4P\T[ST\?_ 3$+_TX,IO\N!NO;5_
MAK?V+9[X65S_O3;LG_26U<VZY(F_ +5Q>EGIW+0V]#VNGW.X7/61+/BZ0?>1
MA4<'$\]-\+*'I?:BGG70''T"5.CPYQ.$^\V]KPNX/BC*1&0%IONB*@7UH=X%
MRD3<)B7<3%Z%/B+(X5XI00XZ=M\DC'GM3W(K;>0!^)US:SYHN\>DYM\>Q>57
M#^@[8^'LO75B!QAZ=]WZ9OMZ-I43V19KN#^?<;CN#&97S>'ZF,V[^EG8$;HD
M&)D_1J_7X>YX4MHT%]8A+J=H2G#Z!?*F%Y 9@7&8PFL*1^LYP]^3*YZW^TL[
M^@RFA''$?./8&L9G<"4>.UD[RZB:B6H?HVZL/KT5_DK<"D]$O%&4!<*17MF_
MU'&5.0!7(EY 2^"<WV>\]6/]IA]KFP3X02'J9:G<;<0L4*Q98*R-#T"C)GZY
M2Q>.[\0=!^(R9J$6T0Q]&9_<RR=D=%^Y[AO%XU3AJO64_V*=7YSGGUHWWVY;
M\OW#_NF0=J0S>C'XULYT\@^I'\.38O/+Z.$TBXHI(_/0;F#M_EH>=AJ%IJ%*
MY\=G5ZGK?*/6RK;JRO<?1NM&SJGMK)WIZ:G38_O:L;H_*M]:US_N::YWVW_J
M-Y_,X5C^<M/#15U]LJ^KN9/+GT^GI[EZ4==(H:=U?JC.Z:5<T_IRX>):HA>G
M^)_[UE#^Y^'Q:K^:UKOMX_WK?+[>K5IG_URCFZ?CVT+ZX5NJGBL4I+,;G3X\
MY =:;V3\Z)JW>KKFW-,OC^.<?=^\N$]]2UF7*//S>/^+GFJH>G&<-YLH<WUF
M5>_UNJ.KQ"BTQVGMH3II'BO%6IVU=T<PI9C:A/_LVP.]_/]02P$"% ,4
M" #(@YY<2B/7#RX#  #W"P  $0              @ $     8V]C<"TR,#(V
M,#0S,"YX<V102P$"% ,4    " #(@YY<8=)W_/T*  !_A@  %0
M    @ %= P  8V]C<"TR,#(V,#0S,%]L86(N>&UL4$L! A0#%     @ R(.>
M7!\_CY=@!P  XE<  !4              ( !C0X  &-O8W M,C R-C T,S!?
M<')E+GAM;%!+ 0(4 Q0    ( ,B#GERN80(@[A,  !M9   *
M  "  2 6  !E>#DY+3$N:'1M4$L! A0#%     @ R(.>7 99)/SP$@  NI@
M  L              ( !-BH  &9O<FTX+6LN:'1M4$L%!@     %  4 -@$
' $\]      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cocp-20260430.xsd" xlink:type="simple"/>
    <context id="AsOf2026-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001412486</identifier>
        </entity>
        <period>
            <startDate>2026-04-30</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-04-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-04-30" id="Fact000004">0001412486</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-04-30" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-04-30" id="Fact000010">2026-04-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-04-30" id="Fact000011">Cocrystal Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-04-30" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-04-30" id="Fact000013">001-38418</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-04-30" id="Fact000014">35-2528215</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-04-30" id="Fact000015">19805     N. Creek Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-04-30" id="Fact000016">Bothell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-04-30" id="Fact000017">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-04-30" id="Fact000018">98011</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-04-30" id="Fact000019">(877)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-04-30" id="Fact000020">262-7123</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-04-30" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-04-30" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-04-30" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-04-30" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-04-30" id="Fact000025">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2026-04-30" id="Fact000026">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-04-30" id="Fact000027">COCP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-04-30" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
